Application Sponsors
ANDA 040430 | BIONPHARMA INC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 250MG | 0 | ETHOSUXIMIDE | ETHOSUXIMIDE |
FDA Submissions
| ORIG | 1 | AP | 2002-10-28 | |
LABELING; Labeling | SUPPL | 4 | AP | 2008-03-03 | |
LABELING; Labeling | SUPPL | 5 | AP | 2009-12-10 | |
LABELING; Labeling | SUPPL | 6 | AP | 2011-12-27 | |
REMS; REMS | SUPPL | 7 | AP | 2012-10-19 | |
LABELING; Labeling | SUPPL | 8 | AP | 2014-01-07 | STANDARD |
LABELING; Labeling | SUPPL | 13 | AP | 2020-04-01 | STANDARD |
LABELING; Labeling | SUPPL | 19 | AP | 2022-02-16 | STANDARD |
Submissions Property Types
SUPPL | 5 | Null | 7 |
SUPPL | 6 | Null | 15 |
SUPPL | 7 | Null | 17 |
SUPPL | 8 | Null | 15 |
SUPPL | 13 | Null | 7 |
SUPPL | 19 | Null | 7 |
TE Codes
CDER Filings
BIONPHARMA INC
cder:Array
(
[0] => Array
(
[ApplNo] => 40430
[companyName] => BIONPHARMA INC
[docInserts] => ["",""]
[products] => [{"drugName":"ETHOSUXIMIDE","activeIngredients":"ETHOSUXIMIDE","strength":"250MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ETHOSUXIMIDE","submission":"ETHOSUXIMIDE","actionType":"250MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)